摘要
纳米科学的前沿无疑是将纳米技术应用于医药研究中。在过去的几十年里,由于纳米结构的大家族如纳米粒(NPS),脂质纳米载体等具有表面效应,已发展到可作为药物输送系统(DDS)。然而,这些药物这些纳米载体还在纳米计量方面开设了新的领域,同时需要一个精确的形态特征和近原子分辨率,以便在提供给医生前确定其元素组成,同时排除在合成过程中存在的污染物,以确保生物相容性。经典透射(TEM)和扫描电子显微镜(SEM)技术经常要对形态进行准确分析,尤在水合胶体系统中。此项研究需要特定的技术如环境扫描电镜或低温制备。分析电子显微镜(AEM)技术如电子能量损失谱(EELS)、X射线能量色散谱(EDXS)等来确定系统的基本组成。本文将讨论电子显微镜(EM)的重要性,其为二十一世纪医药研究的可靠工具,我们将集中关注纳米粒子(银和碳纳米颗粒,纳米液晶)和囊泡(脂质体和囊泡)不同种源的优势和局限性。
关键词: 药物输送系统,电子显微镜,X射线能量色散谱,纳米,纳米技术,纳米毒理学,药物研究。
图形摘要
Current Drug Targets
Title:Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Volume: 16 Issue: 13
Author(s): Luciana Dini, Elisa Panzarini, Stefania Mariano, Daniele Passeri, Melania Reggente, Marco Rossi and Cristian Vergallo
Affiliation:
关键词: 药物输送系统,电子显微镜,X射线能量色散谱,纳米,纳米技术,纳米毒理学,药物研究。
摘要: One of the frontier of nanoscience is undoubtedly represented by the use of nanotechnologies in the pharmaceutical research. During the last decades a big family of nanostructures that have a surface-acting action, such as NanoParticles (NPs), lipid nanocarriers and many more, have been developed to be used as Drug Delivery Systems (DDSs). However, these nanocarriers opened also new frontiers in nanometrology, requiring an accurate morphological characterization, near atomic resolution, before they are really available to clinicians to ascertain their elemental composition, to exclude the presence of contaminants introduced during the synthesis procedure and to ensure biocompatibility. Classical Transmission (TEM) and Scanning Electron Microscopy (SEM) techniques frequently have to be adapted for an accurate analysis of formulation morphology, especially in case of hydrated colloidal systems. Specific techniques such as environmental scanning microscopy and/or cryo preparation are required for their investigation. Analytical Electron Microscopy (AEM) techniques such as Electron Energy-Loss Spectroscopy (EELS) or Energy-Dispersive X-ray Spectroscopy (EDXS) are additional assets to determine the elemental composition of the systems. Here we will discuss the importance of Electron Microscopy (EM) as a reliable tool in the pharmaceutical research of the 21st century, focalizing our attention on advantages and limitations of different kind of NPs (in particular silver and carbon NPs, cubosomes) and vesicles (liposomes and niosomes).
Export Options
About this article
Cite this article as:
Luciana Dini, Elisa Panzarini, Stefania Mariano, Daniele Passeri, Melania Reggente, Marco Rossi and Cristian Vergallo , Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450116666150531160851
DOI https://dx.doi.org/10.2174/1389450116666150531160851 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Self-Assembling Peptides: Potential Role in Tumor Targeting
Current Pharmaceutical Biotechnology New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Liposomes: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Letters in Drug Design & Discovery Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy
Current Pharmaceutical Design Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View
Current Pharmaceutical Design Naturally Occurring NF-κB Inhibitors
Mini-Reviews in Medicinal Chemistry Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies Specificity of Binding in Protein Kinases
Current Enzyme Inhibition On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Current Drug Metabolism Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design RNA G-Quadruplex: The New Potential Targets for Therapy
Current Topics in Medicinal Chemistry Cannabis Phenolics and their Bioactivities
Current Medicinal Chemistry Natural Small Molecules as Stabilizers and Activators of Cancer-Associated NQO1 Polymorphisms
Current Drug Targets Targeting Cancer Stem Cells: Promises and Challenges
Anti-Cancer Agents in Medicinal Chemistry